Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
The search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00057/full |
id |
doaj-c66aeeeef5bb48ef8b916741d126fcbd |
---|---|
record_format |
Article |
spelling |
doaj-c66aeeeef5bb48ef8b916741d126fcbd2020-11-24T23:38:56ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402013-06-01410.3389/fpsyt.2013.0005755493Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward riskDonald F Smith0Psychiatric Hospital of Aarhus UniversityThe search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids as well as brain-derived neurotropic factor. Additional approaches to identifying biomarkers of TRD have dealt with cerebrospinal fluid analysis, magnetic resonance imaging, and positron emission tomography. Some studies have also investigated potential genetic and epigenetic factors in TRD. Most studies have, however, used a post hoc experimental design that failed to determine the association between biomarkers and the initial risk of TRD. Particular attention in future studies should be on shifting the experimental paradigm towards procedures that can determine the risk for developing treatment resistance in untreated depressed individuals.http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00057/fullCytokinesImmune Systembrain imagingbiomarkersdepressive disordersexperimental design |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Donald F Smith |
spellingShingle |
Donald F Smith Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk Frontiers in Psychiatry Cytokines Immune System brain imaging biomarkers depressive disorders experimental design |
author_facet |
Donald F Smith |
author_sort |
Donald F Smith |
title |
Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
title_short |
Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
title_full |
Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
title_fullStr |
Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
title_full_unstemmed |
Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
title_sort |
quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Psychiatry |
issn |
1664-0640 |
publishDate |
2013-06-01 |
description |
The search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids as well as brain-derived neurotropic factor. Additional approaches to identifying biomarkers of TRD have dealt with cerebrospinal fluid analysis, magnetic resonance imaging, and positron emission tomography. Some studies have also investigated potential genetic and epigenetic factors in TRD. Most studies have, however, used a post hoc experimental design that failed to determine the association between biomarkers and the initial risk of TRD. Particular attention in future studies should be on shifting the experimental paradigm towards procedures that can determine the risk for developing treatment resistance in untreated depressed individuals. |
topic |
Cytokines Immune System brain imaging biomarkers depressive disorders experimental design |
url |
http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00057/full |
work_keys_str_mv |
AT donaldfsmith questforbiomarkersoftreatmentresistantdepressionshiftingtheparadigmtowardrisk |
_version_ |
1725515261030694912 |